Michael Skynner changed role as Chief Technology Officer at BICYCLE THERAPEUTICS PLC.
“following the transition of Michael Skynner, Ph.D. to the newly-created role of Chief Technology Officer of the Company as of the Effective Date.”
Source-grounded facts extracted from BICYCLE THERAPEUTICS PLC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Michael Skynner changed role as Chief Technology Officer at BICYCLE THERAPEUTICS PLC.
“following the transition of Michael Skynner, Ph.D. to the newly-created role of Chief Technology Officer of the Company as of the Effective Date.”
Alistair Milnes was appointed as Chief Operating Officer at BICYCLE THERAPEUTICS PLC.
“On January 5, 2022, Bicycle Therapeutics plc (the “Company”) announced the appointment of Alistair Milnes, age 48, as the Company’s Chief Operating Officer, effective as of January 3, 2022”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.